Showing results (2491-2500 of 2,897) with videos related to

Sort By:
Pageof 290
Molecular Diversity|June 30, 2025
Oxidative stress and antioxidant therapeutics in autism spectrum disorder: a biochemical and structure-activity relationship perspectiveAkansha Pal, Falguni Goel, Anushka Sharma, et al.
Molecular Diversity|June 25, 2025
Recent advances in pyrazolo[3,4-b]pyridine chemistry: synthesis techniques and biological activityAnhar Abdel-Aziem, Sawsan A Fouad
Molecular Diversity|June 26, 2025
Discovery of FLF-15 as a novel selective inhibitor of ADAM17 to prevent hepatocellular carcinoma metastasisQing Li, Dao-Ping Wang, Ting Zhong, et al.
Molecular Diversity|June 24, 2025
Integrative transcriptomic and structural analysis identifies PTGS2 as a key target in ischemic stroke associated with neuroinflammationSaleh I Alaqel, Abida Khan, Mashael N Alanazi, et al.
Molecular Diversity|April 10, 2025
In vitro larvicidal activity of selected azabenzimidazole and diarylquinoline derivatives against Anopheles gambiae and in silico mechanistic analysisKola A Oluwafemi, Anthony F Adeforiti, Oluwatoba E Oyeneyin, et al.
Molecular Diversity|April 16, 2025
Identification of low-toxicity DNA topoisomerase I inhibitors with potential blood-brain barrier penetrability for glioblastoma therapy: structure-based virtual screening reveals promising novel ScaffoldsYa-Lin Li, Jun Mao, Zhong Cheng, et al.
Molecular Diversity|April 2, 2025
Searching potential GSK-3β inhibitors from marine sources using atomistic simulationsTran Thi Hoai Van, Minh Quan Pham, Truong Thi Thu Huong, et al.
Molecular Diversity|May 13, 2025
From pharmacophore predictions to pharmaceutical possibilities: an integrated approach to screen M3 selective muscarinic receptor antagonistSirat K Gill, Swati Kumari, Bichitra K Biswal, et al.
Molecular Diversity|May 13, 2025
Identifying potent inhibitors for Mycobacterium tuberculosis MabA (FabG1)Debashis Panda, Jitendra Maharana, Arjun Sharma, et al.
Molecular Diversity|May 21, 2025
Discovery of novel potential 11β-HSD1 inhibitors through combining deep learning, molecular modeling, and bio-evaluationXiaodie Chen, Liang Zou, Lu Zhang, et al.
Pageof 290